Source: CosmosID Blog

CosmosID Blog Advanced Insights into Alzheimer's Disease through Comprehensive Metabolomics Profiling

Grabrucker S, Marizzoni M, Silajdžić E, et al. Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis. Brain. 2023;146:4916-4934. https://doi.org/10.1093/brain/awad303 Our metabolomics capabilities were recently highlighted in an Alzheimer's Fecal Microbiota Transplant (FMT) study published in BRAIN by researchers at University College Cork in Ireland. By utilizing untargeted metabolomics, Grabrucker, Marizzoni, and colleagues underpinned novel microbiome-mediated mechanisms...The post Advanced Insights into Alzheimer's Disease through Comprehensive Metabolomics Profiling appeared first on CosmosID.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Manoj Dadlani's photo - CEO of CosmosID

CEO

Manoj Dadlani

CEO Approval Rating

86/100

Read more